Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Onconova Therapeutics Inc...

    NASDAQ: ONTX · Real-Time Price · USD
    1.00
    0.00 (0.00%)
    At close: Apr 02, 2024, 8:00 PM

    Onconova Therapeutics Statistics

    Share Statistics

    Onconova Therapeutics has 21M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 21M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 701

    FTD / Avg. Volume

    n/a
    		 0.55%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -0.83 and the forward PE ratio is null. Onconova Therapeutics's PEG ratio is -0.36.

    PE Ratio

    n/a
    		 -0.83

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 69.24

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 1.47

    P/FCF Ratio

    n/a
    		 -0.87

    PEG Ratio

    n/a
    		 -0.36
    Financial Ratio History

    Enterprise Valuation

    Onconova Therapeutics has an Enterprise Value (EV) of -5.17M.

    EV / Sales

    n/a
    		 -22.88

    EV / EBITDA

    n/a
    		 0.25

    EV / EBIT

    n/a
    		 0.29

    EV / FCF

    n/a
    		 0.29

    Financial Position

    The company has a current ratio of 2.46, with a Debt / Equity ratio of -316247.81.

    Current Ratio

    n/a
    		 2.46

    Quick Ratio

    n/a
    		 2.3

    Debt / Equity

    n/a
    		 -316247.81

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is -177.55% and Return on Invested Capital is 0%.

    Return on Equity

    n/a
    		 -177.55%

    Return on Assets

    n/a
    		 -83.53%

    Return on Invested Capital

    n/a
    		 0%

    Revenue Per Employee

    n/a
    		 $14,125

    Profits Per Employee

    n/a
    		 $-1,184,250

    Employee Count

    n/a
    		 16

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 -159.15K

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 55.91% in the last 52 weeks. The beta is 1.35, so Onconova Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.35

    52-Week Price Change

    n/a
    		 55.91%

    50-Day Moving Average

    n/a
    		 0.8

    200-Day Moving Average

    n/a
    		 0.77

    Relative Strength Index (RSI)

    n/a
    		 36.95

    Average Volume (20 Days)

    n/a
    		 126,338

    Income Statement

    In the last 12 months, Onconova Therapeutics had revenue of 226K and earned -18.95M in profits. Earnings per share was -0.9.

    Revenue

    n/a
    		 226K

    Gross Profit

    n/a
    		 226B

    Operating Income

    n/a
    		 -20.3M

    Net Income

    n/a
    		 -18.95M

    EBITDA

    n/a
    		 -20.28M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -0.9
    Full Income Statement

    Balance Sheet

    The company has 20.82M in cash and 0 in debt, giving a net cash position of 20.82M.

    Cash & Cash Equivalents

    n/a
    		 20.82M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -482.63M

    Total Assets

    n/a
    		 18.17M

    Working Capital

    n/a
    		 8.73M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -17.93M and capital expenditures -14K, giving a free cash flow of -17.95M.

    Operating Cash Flow

    n/a
    		 -17.93M

    Capital Expenditures

    n/a
    		 -14K

    Free Cash Flow

    n/a
    		 -17.95M

    FCF Per Share

    n/a
    		 -0.86
    Full Cash Flow Statement

    Margins

    Gross margin is 100000000%, with operating and profit margins of -8981.42% and -8384.07%.

    Gross Margin

    n/a
    		 100000000%

    Operating Margin

    n/a
    		 -8981.42%

    Pretax Margin

    n/a
    		 -8384.07%

    Profit Margin

    n/a
    		 -8384.07%

    EBITDA Margin

    n/a
    		 -8974.34%

    EBIT Margin

    n/a
    		 -8981.42%

    FCF Margin

    n/a
    		 -7940.71%

    Dividends & Yields

    ONTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -121.08%

    FCF Yield

    n/a
    		 -114.68%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ONTX.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 21, 2021. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 May 21, 2021

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -39.46

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist